Suchergebnisse - "Zou, Yutong"

PubPharm (126)

91

Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy

enthalten in: International urology and nephrology | 2021

von Zhao, L. | Ren, H. | Zhang, R. | +6

92

The effect of anticancer treatment on cancer patients with COVID‐19 : A systematic review and meta‐analysis

enthalten in: Cancer Medicine | 2021

von Liu, H. | Yang, D. | Chen, X. | +4

93

Evaluation of bone metabolism‐associated biomarkers in Tibet, China

enthalten in: Journal of Clinical Laboratory Analysis | 2021

von Zou, Y. | Liu, Z. | Li, H. | +13

94

联合评估肾小球基底膜厚度和肾小管基底膜厚度可提高糖尿病肾病进展为终末期肾脏病的预测能力

enthalten in: Journal of Diabetes | 2021

von Zhao, L. | Zhang, J. | Lei, S. | +11

95

The effect of ALDH2 rs671 gene mutation on clustering of cardiovascular risk factors in a big data study of Chinese population : associations differ between the sexes

enthalten in: BMC cardiovascular disorders | 2020

von Wang, D. | Zou, Y. | Yu, S. | +6

96

The effect of ALDH2 rs671 gene mutation on clustering of cardiovascular risk factors in a big data study of Chinese population: associations differ between the sexes

enthalten in: BMC cardiovascular disorders | 2020

von Wang, D. | Zou, Y. | Yu, S. | +6

97

Associations Between High-Altitude Residence and End-Stage Kidney Disease in Chinese Patients with Type 2 Diabetes

enthalten in: High altitude medicine & biology | 2020

von Zhao, L. | Wang, X. | Wang, T. | +8

98

Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS

enthalten in: Metabolomics : Official journal of the Metabolomic Society | 2020

von Lv, D. | Zou, Y. | Zeng, Z. | +5

99

Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS

enthalten in: Metabolomics | 2020

von Lv, D. | Zou, Y. | Zeng, Z. | +5

100

Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS

enthalten in: Metabolomics | 2020

von Lv, D. | Zou, Y. | Zeng, Z. | +5

[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[13]